Peer Schatz

Cellestis Ltd. develops, manufactures and markets medical diagnostic products. It develops and markets QuantiFERON technology products for medical diagnosis and scientific research. The QuantiFERON technology is a patented whole blood method for detecting cell mediated immune responses of T cell lymphocytes using whole blood samples. Its product portfolio includes QuantiFERON-CMI kit, an in vitro laboratory test for the measurement of cell mediated immune responses in humans using whole blood, QuantiFERON-TB Gold, an in vitro diagnostic test for the detection of mycobacterium tuberculosis infection. The company was founded in 2000 and is headquartered in Chadstone, Australia.

Exiqon A/S engages in the development of solutions for ribonucleic acid research and analysis through its Locked Nucleic Acid proprietary technology. Its products and services are used by researchers in academia, biotech, and pharmaceutical companies around the world to make discoveries about the correlation between gene activity and the development of disease. The company was founded by Mikael Ørum, Henrik Ørum and Troels Koch on November 1, 1995 and is headquartered in Copenhagen, Denmark.

QIAGEN GmbH provides products for preanalytical sample preparation and molecular diagnostics solutions. It develops and markets consumable products and automated solutions to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. The company was founded in 1984 and is headquartered in Hilden, Germany.

Part of QIAGEN NV, Tian Gen Biotech (Beijing) Co. Ltd is a Chinese company that engages in the development of nucleic acid preparation products. The company is based in Beijing, China. Tian Gen Biotech (Beijing) Co. was acquired by QIAGEN NV on July 12, 2005 for $0.24 million.

Forum Mondial de L'Economie engages in the foremost political, business and cultural organizations to shape global, regional and industry agendas. The company was founded by Klaus Schwab in 1971 and is headquartered in Cologny, Switzerland.

Part of QIAGEN NV, QIAGEN North American Holdings, Inc. provides biotechnology services. The company is based in Germantown, MD.

Qiagen, Inc. provided technologies for separating, purifying and handling nucleic acids. The company was founded in 1988 and was headquartered in Germantown, MD.

QIAGEN Sciences, Inc. manufactures chemical products. It offers assay technologies and products in areas such as pre-analytical sample preparation and assay solutions in research for life sciences, applied testing and molecular diagnostics. The company's products are sold to academic research markets, to pharmaceutical and biotechnology companies, to applied testing customers (such as in forensics, veterinary, biodefense and industrial applications) as well as to molecular diagnostics laboratories. QIAGEN Sciences was founded in January, 2002 and is located in Germantown, MD

QIAGEN Aarhus A/S develops and markets software and hardware solutions and consultancy services within bioinformatics. Its products include workbench, server solutions, database, and modules. The company was founded by Thomas Knudsen and Bjarne Knudsen in 2004 and is headquartered in Aarhus, Denmark.

QIAGEN Marseille SA is a molecular diagnosis company, which focuses on the development and marketing of diagnostic tests in the field of oncology. Its products are used for diagnosis, prognosis and monitoring of patients with leukemia. The company was founded by Vincent Fert, Stéphane Debono, and Fabienne Hermitte on September 23, 1999 and is headquartered in Marseille, France.

Corbett Life Science Pty Ltd. manages a group of biotechnology companies that design, manufacture, and distribute instrumentation systems for the life sciences sector. The company was founded by John Corbett Sr. and John Corbett Jr. in 1988 and is headquartered in Sydney, Australia.

SABiosciences Corp. develops and markets technologies for genetic and medical research. It is a biotechnology company that envisions a new and systematic approach to biological research in the post-genomic era. The company was founded in 1998 and is headquarterd in Frederick, MD.

Biotype AG is an innovative company of the biotechnology branch located in Dresden, Germany. Since 1999 they develop, produce and distribute molecular biological tests for fast and sensitive PCR diagnostics employed in forensics, paternity testing, human and veterinary medicine, as well as construction surveys. Their portfolio varies from test kits for genetic identification of humans and animals, in vitro diagnostics in human medicine, to molecular detection of human and veterinary pathogens. All products are based on the technology of multiplex PCR for subsequent analysis using microarray detection, capillary gel electrophoresis or Real-Time-PCR.

QIAGEN Lake Constance GmbH develops and produces optical measurement devices for medical, environmental and industrial applications. The company was founded by Thomas Wiest, Klaus Haberstroh, Roland Sackers, Peer Michael Schatz, and Jörg Schickedanz in 1997 and is headquartered in Stockach, Germany.

Qiagen AG manufactures biological products for purification, transfection, and amplification of nucleic acid and proteins. The company was founded on September 15, 1994 and is headquartered in Basel, Switzerland.

Part of QIAGEN NV, QIAGEN KK is a subsidiary company based in Japan. QIAGEN KK is committed to advancing precision medicine and enabling researchers and healthcare professionals to make informed decisions based on molecular insights. QIAGEN KK operates in the life sciences industry, specializing in providing innovative solutions for molecular diagnostics, genomics, and pharmaceutical research. With a focus on improving healthcare outcomes, QIAGEN KK offers a wide range of products and services, including genetic testing kits, laboratory instruments, and bioinformatics software.

Part of QIAGEN NV, QIAGEN Pty Ltd. provides commercial, physical and biological research and development solutions.

DxS Ltd. is a personalized medicine company which engages in the development and manufacture of companion diagnostic products. Its products make use of molecular diagnostics to aid doctors and drug companies in selecting therapies for patients. It offers its products, technology, and services to the healthcare industry to enable the delivery of safe and effective medicines. The company was founded by David Whitcombe in 2001 is headquartered in Manchester, the United Kingdom.

Part of QIAGEN NV, QIAGEN Gaithersburg, Inc. is a company that manufactures and supplies diagnostic devices. The company is based in Gaithersburg, MD.

Qiagen Ltd. engages in other human health activities. The company was incorporated on October 4, 1993 and is headquartered in Manchester, the United Kingdom

Part of QIAGEN NV, QIAGEN Hamburg GmbH is a German company that delivers sample to insights solutions, enabling customers to unlock insights from the building blocks of life - DNA, RNA, and proteins. The company is based in Hilden, Germany. The CEOs are Peer Michael Schatz and Roland Sackers. The company was founded in 2013.

Part of QIAGEN NV, QIAGEN Benelux BV provides biotechnology services. The company is based in Venlo, Netherlands. QIAGEN Benelux was founded in 1984.

Part of Advanced Medical Technology Association, AdvaMedDx operates as a trade association representing diagnostics manufacturers. The company is based in Washington. The CEO of the American company is Scott Whitaker.

LDN Labor Diagnostika Nord GmbH & Co. KG is a German medium-sized company that specializes in the development, production, and marketing of immunoassays for medical laboratories, food analysis, and biomedical research. LDN provides over 200 products in more than 80 countries, serving customers from clinical labs, research facilities, pharmaceutical companies, and the food industry. All of LDN's products are manufactured at its headquarters in Nordhorn, DE. The private company was founded in 1996 and has grown to become a leading player in the market for immunoassays for biogenic amines, with over 35 employees.

Amnisure International LLC manufactures and distributes medical assays in determining the presence of a rupture of fetal membranes in pregnant women. The firm’s technology includes Amnisure ROM test, PAMG-1 Protein, Lateral Flow, Alpha Fetoprotein and Biomarker Testing for PROM and Non-Invasive PROM & pPROM testing. The company was founded in 2005 and is headquartered in Boston, MA.

Part of QIAGEN NV, Research Biolabs Sdn. The company is based in Kuala Lumpur, Malaysia. Bhd. is a Malaysian company that distributes imaging, reagents, liquid dispensing & laser micro dissection systems and other life science kits.

Qiagen SRL is engaged in providing assay technologies. The company is headquartered in Milan, Italy.

Research Biolabs Pte Ltd. was founded in 1994 and is based in Singapore, Singapore. The Singaporean company distributes polymerase chain reaction cyclers, liquid dispensing machines, and laser microdissection systems.

Part of Calibre Scientific, Inc., QIAGEN Canada, Inc. is a Canadian company that develops crystallization preparation tools and solutions and related screening technology. The company is based in Toronto, Canada. QIAGEN Canada was acquired by Calibre Scientific, Inc. from QIAGEN NV on January 08, 2020.

Quantabio supplies reagents for RT and PCR applications in life science, drug discovery and public health laboratories. Its products include sample preparation, reverse transcription, genotyping and microRNA profiling. The company was founded by Neil J. Campbell in June 2001 and is headquartered in Beverly, MA.

Part of QIAGEN NV, QIAGEN Manchester Ltd. is a pharmaceutical manufacturing company. The company is based in Manchester, UK. QIAGEN Manchester was founded in 2001.

Part of QIAGEN NV, QIAGEN Sciences LLC is a company that manufactures and distributes sample and assay technology products for preanalytical sample preparations. The company is based in Germantown, MD.

Centogene AG focuses on genetic and biochemical diagnostic testing services for rare hereditary disorders. The firm operates through the offices located in Freiburg, Dubai and Noida. The company was founded by Arndt Rolfs in 2006 and is headquartered in Rostock, Germany.

Part of QIAGEN NV, Qiagen Hong Kong Pte Ltd. is a company that manufactures and wholesales laboratory equipment. The company is based in Hong Kong, Hong Kong.

INDICAL BIOSCIENCE GmbH provides solutions for molecular diagnostics for vet-specific applications. It offers diagnostics for better animal and human health. The company was founded in 1996 and is headquartered in Leipzig, Germany.

Siemens Healthcare GmbH provides healthcare services. Its products and services include medical imaging, ultrasound, laboratory diagnostics, point-of-care testing, healthcare, clinical specialties & diseases. It operates through following business segments: Imaging, Diagnostics and Advanced Therapies. The Imaging segment offers diagnostic imaging products and a broad portfolio of advanced imaging and ultrasound systems and solutions. The Diagnostics segment offers products, services and solutions, including a broad array of testing applications, in the areas of laboratory, point of care and molecular diagnostics. The Advanced Therapies segment is a supplier of advanced therapy products, services and solutions to the therapy departments of healthcare providers. The company was founded on May 1, 2015 and is headquartered in Erlangen, Germany.

PS Capital Management GmbH provides asset management services. The company is based in Dusseldorf, Germany. The CEO of the German company is Monheim am Rhein.

Qiagen Healthcare Biotechnologies Systems Ltd. engages in the activities related to maintaining of intangible assets. It involves in the production of products which allow to collect, stabilze and archive DNA and blood related to the forensics life science Business. The company was founded on September 10, 2018 and is headquartered in Manchester, The United Kingdom.

Resolve BioSciences GmbH is a German company that applies molecular cartography to provide scientists with a high-resolution view of spatial biology. The company is based in Monheim am Rhein, Germany. The company's proprietary technology offers full spatial context at subcellular resolution, which helps scientists detect individual transcripts and rare signals to interpret fundamental biology. The company's technology is used in critical fields such as oncology, neuroscience, infectious disease, and agriculture. The company was founded by Jason T. Gammack, and John Stark has been the CEO of the company since 2023.

Part of QIAGEN NV, QIAGEN Deutschland Holding GmbH functions as an investment holding German company. The company is based in Hilden, Germany. The company was founded in 2006. The CEO is Roland Sackers.